Division of Maternal and Fetal Medicine, Department of Obstetrics and Gynaecology, Mount Sinai Hospital, University of Toronto, Toronto, Canada.
Faculty of Medicine, University of Toronto, Toronto, Canada.
J Matern Fetal Neonatal Med. 2020 Aug;33(16):2841-2851. doi: 10.1080/14767058.2018.1560410. Epub 2019 Jan 7.
Although brainstem gliomas are a rare group of neoplasias, when they affect pregnant women, there can be challenges with diagnosis and management. This study describes a case of brainstem glioma diagnosed in pregnancy and systematically reviews the literature on brainstem gliomas in pregnancy to provide guidance for management. We searched five databases from inception until October 2016 using subject headings and keywords related to pregnancy and brainstem glioma, and included original research articles that described pregnancy outcomes in women with brainstem glioma. Data extraction and quality assessment using the Joanna Briggs Institute Critical Appraisal Checklist for case reports were performed in duplicate. Outcomes were reported as proportions. The study protocol was registered with the Prospero International Prospective Register of Systematic Reviews (CRD42017060196). We screened 2737 titles and abstracts, and 89 full-texts. Twelve articles describing 17 pregnancies in 16 women were included in the analysis. The median gestational age at presentation was 23 weeks. All but one case presented with neurologic deficit. Magnetic resonance (MRI) imaging conclusively diagnosed all cases. Surgical tumor resection ( = 4) and radiation therapy ( = 3) were successfully undertaken during pregnancy. There were no reported sequelae of maternal oncological management on neonatal wellbeing. Maternal mortality was high (8/16, 50%) both during ( = 5) and within 4 weeks ( = 3) of pregnancy. Pregnancy losses included one pregnancy termination and four miscarriages (associated with maternal mortality). Of the 12 live-born babies, five were premature. Two of these were the result of spontaneous preterm labor and three were delivered prematurely to facilitate glioma management. There was one case of fetal growth restriction. Although the symptoms of brainstem gliomas often mimic those commonly encountered in pregnancy, neurologic deficits warrant urgent investigation. MRI is the diagnostic modality of choice in pregnancy. Brainstem gliomas are associated with high maternal mortality and appropriate management, including surgical tumor resection and radiation therapy, should not be delayed on account of pregnancy. Pregnancy outcomes are favorable although there is a risk of preterm birth.Key messageBrainstem gliomas are associated with high maternal mortality and timely diagnosis using magnetic resonance imaging and treatment including surgical resection and radiation therapy should not be delayed during pregnancy. Pregnancy outcomes are generally favorable except for risk of preterm birth.
尽管脑干神经胶质瘤是一组罕见的肿瘤,但当它们影响到孕妇时,诊断和管理可能会面临挑战。本研究描述了一例在妊娠期间诊断出的脑干神经胶质瘤,并系统地回顾了妊娠期间脑干神经胶质瘤的文献,为管理提供了指导。我们使用与妊娠和脑干神经胶质瘤相关的主题词和关键词,从建库开始到 2016 年 10 月在五个数据库中进行了检索,并纳入了描述脑干神经胶质瘤孕妇妊娠结局的原始研究文章。我们使用 Joanna Briggs 循证卫生保健中心的病例报告质量评价工具(Critical Appraisal Checklist for Case Reports)对数据进行了重复提取和质量评价。结果以比例形式报告。研究方案已在国际前瞻性注册系统评价(Prospero)注册(CRD42017060196)。我们筛选了 2737 篇标题和摘要,以及 89 篇全文。共有 12 篇文章描述了 16 名妇女的 17 例妊娠,纳入了分析。表现时的中位孕龄为 23 周。除 1 例外,所有病例均表现为神经功能缺损。磁共振成像(MRI)成像明确诊断了所有病例。手术肿瘤切除术( = 4)和放疗( = 3)在妊娠期间成功进行。母亲肿瘤管理对新生儿健康状况无不良影响。母亲死亡率高(16 例中有 8 例,50%),包括妊娠期间( = 5)和妊娠后 4 周内( = 3)。妊娠丢失包括一次妊娠终止和 4 次流产(与母亲死亡有关)。在 12 例活产婴儿中,有 5 例早产。其中 2 例是自发性早产,3 例是为了便于胶质瘤治疗而提前分娩。有 1 例胎儿生长受限。尽管脑干神经胶质瘤的症状常与妊娠期间常见的症状相似,但神经功能缺损需要紧急调查。MRI 是妊娠期间的首选诊断方式。脑干神经胶质瘤与高母亲死亡率相关,应及时诊断,包括手术肿瘤切除和放疗,不应因妊娠而延误。尽管存在早产风险,但妊娠结局通常良好。